See the DrugPatentWatch profile for cosentyx

Based on the information available, it is unclear if it is safe to receive live vaccines during Cosentyx (secukinumab) use. Cosentyx is a medication used to treat several conditions, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It is a type of drug known as a monoclonal antibody, which works by targeting and blocking a specific protein in the body that contributes to inflammation [1].

According to the Cosentyx prescribing information, live vaccines should be avoided in patients receiving Cosentyx [1]. This is because the medication may affect the immune system's ability to respond to live vaccines [1]. However, it is important to note that this information is based on the prescribing information for Cosentyx and may not be comprehensive.

It is always recommended to consult with a healthcare provider for personalized medical advice. They can provide more information on the safety of receiving live vaccines during Cosentyx use based on an individual's specific medical history and current health status.

In summary, based on the available information, it is recommended to avoid live vaccines during Cosentyx use. However, it is important to consult with a healthcare provider for personalized medical advice.

Sources:

* [1] Cosentyx (secukinumab) [prescribing information]. Novartis Pharmaceuticals Corporation; 2021. <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>.